FDA's Tissue Reference Group Recognizes Five New BioLab Holdings Amniotic Membrane Allografts as HCT/Ps

The unique amniotic membrane allograft aids in the covering and protection of wounds PHOENIX, Aug. 28, 2025 /PRNewswire/ -- BioLab Holdings, Inc. announced today that five of its amniotic membrane allograft products have received recognition from the Food and Drug Administration's (FDA)...